The coming years may see the advent of distributed implantable devices to support bioelectronic medicinal treatments. Communication between implantable components and between deep implants and the outside world can be challenging. Percutaneous wired connectivity is undesirable and both radiofrequency and optical methods are limited by tissue absorption and power safety limits. As such, there is a significant potential niche for ultrasound communications in this domain. In this paper, we present the design and testing of a reliable and efficient ultrasonic communication telemetry scheme using piezoelectric transducers that operate at 320 kHz frequency.A key challenge results from the multi-propagation path effect. Therefore, we present a method, using short pulse sequences with relaxation intervals. To counter an increasing bit, and thus packet, error rate with distance, we have incorporated an error correction encoding scheme. We then demonstrate how the communication scheme can scale to a network of implantable devices. We demonstrate that we can achieve an effective, error-free, data rate of 0.6 kbps, which is sufficient for low data rate bioelectronic medicine applications. Transmission can be achieved at an energy cost of 642 nJ per bit data packet using on/off power cycling in the electronics. achieve therapy. However, an important development is to progress from open-loop, pacemaker type, stimuli to closed-loop control methodologies which modify therapeutic stimuli according to need. Such systems will therefore also need sensors from perhaps downstream organs which can provide physiological information. Examples include blood oxygen and glucose levels, heart rate, chemical sensing, mechanical motion, and bioelectronic activity [7,8].Bioelectronic therapies would need to comprise an active implant (Active Implantable Medical Device or AIMD) which can gather information, perform processing and determine stimulus. As downstream organs are geographically separated by tens of centimeters, a possible architecture is for a central implant unit together with satellite units called bioelectronic nodes (BeNs) which provide sensing and perhaps stimulation. This configuration can be seen in Figure 1. Ideally, such bioelectronic nodes would be injected to their target locations rather than be surgically inserted. As such, the devices would need to be in the mm size range. Such devices would have small batteries and thus be limited in operation. i.e., duty cycles would be for a few milliseconds each hour or day. However, such operation is sufficient for bioelectronic therapies which only need to infrequently monitor physiological responses.